Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD51 | Q06609 | 11/20 | 1.00 |
| ▸ | RAD1 | O60671 | 2/20 | 1.00 |
| ▸ | BCL2A1 | Q16548 | 5/20 | 0.66 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | BCL2 | P10415 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | BID | P55957 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.48 |
| ▸ | BCL2L2 | Q92843 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15758872 | 1.00 | RAD51 (1.00) | RAD51RAD1BCL2A1MAPTHSD17B10 | |
| SCHEMBL17208336 | 0.88 | RAD51 (0.78) | RAD51RAD1BCL2A1MAPTHSD17B10 | |
| SCHEMBL15758657 | 0.88 | RAD51 (0.78) | RAD51RAD1BCL2A1MAPTHSD17B10 | |
| SCHEMBL15758474 | 0.86 | RAD51 (0.75) | RAD51RAD1BCL2A1MAPTHSD17B10 | |
| SCHEMBL17202955 | 0.86 | RAD51 (0.75) | RAD51RAD1BCL2A1MAPTHSD17B10 | |
| SCHEMBL15758183 | 0.85 | RAD51 (0.74) | RAD51RAD1BCL2A1MAPTHSD17B10 | |
| SCHEMBL17201949 | 0.85 | RAD51 (0.74) | RAD51RAD1BCL2A1MAPTHSD17B10 | |
| SCHEMBL15758221 | 0.84 | RAD51 (0.72) | RAD51RAD1BCL2A1MAPTHSD17B10 | |
| SCHEMBL15758589 | 0.81 | RAD51 (0.67) | RAD51RAD1BCL2A1MAPTALDH1A1 | |
| SCHEMBL15758723 | 0.79 | RAD51 (1.00) | RAD51RAD1BCL2A1MAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250345443-A1 | PHARMACEUTICAL COMPOUND AND USE THEREOF | DUALITY BIOLOGICS SUZHOU CO LTD (CN) | 2025-11-13 | — | — | US | claimed |
| US-20250320192-A1 | DEUTERIUM-ENRICHED PIPERIDINONYL-OXOISOINDOLINYL ACETAMIDES AND METHODS OF TREATING MEDICAL DISORDERS USING SAME | DEUTERX LLC (US) | 2025-10-16 | — | — | US | claimed |
| US-12446430-B2 | Display panel with dummy pixel space, display device and display driving method | BEIJING BOE OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2025-10-14 | — | — | US | claimed |
| US-12413931-B2 | Method and system for optimizing the position of a user equipment | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-09-09 | — | — | US | claimed |
| EP-4610261-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | Neushen Therapeutics (Shanghai) Co., Ltd (CN) | 2025-09-03 | — | — | EP | claimed |
| US-12373929-B2 | Underwater image color restoration method and apparatus, and underwater video color restoration method and apparatus | ARASHI VISION INC. (CN) | 2025-07-29 | — | — | US | claimed |
| CN-120192324-A | Heterocyclic compound, pharmaceutical composition and application | 上海医药集团股份有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120084320-A | SINS/RDOSB joint positioning method and system based on periodic sound source field | 东南大学南通海洋高等研究院 | 2025-06-03 | — | — | CN | claimed |
| CN-119762233-A | Investment optimization method and device | 中国长城科技集团股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119670601-A | Temperature distribution prediction method suitable for horizontal well multistage fracturing process | 北京信息科技大学 | 2025-03-21 | — | — | CN | claimed |
| US-20230242504-A1 | DEUTERIUM-ENRICHED PIPERIDINONYL-OXOISOINDOLINYL ACETAMIDES AND METHODS OF TREATING MEDICAL DISORDERS USING SAME | DEUTERX LLC (US) | 2023-08-03 | — | — | US | claimed |
| EP-4014610-B1 | POSITIONING | FRAUNHOFER GES FORSCHUNG (DE) | 2023-07-19 | — | — | EP | claimed |
| US-11535603-B1 | Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using same | DEUTERX, LLC (US) | 2022-12-27 | — | — | US | claimed |
| CN-115459751-A | High-voltage switch assembly based on SiC MOSFET series connection | 重庆大学 | 2022-12-09 | — | — | CN | claimed |
| US-20220286812-A1 | Method and System for Optimizing the Position of a User Equipment | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2022-09-08 | — | — | US | claimed |
| EP-4014610-A1 | POSITIONING | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2022-06-22 | — | — | EP | claimed |
| US-11363963-B2 | Method and device for determining the hydration, fitness and nutrition status of a human body | CELLA MEDICAL, INC. | 2022-06-21 | — | — | US | claimed |
| CN-114088433-A | Track circuit analog load equipment | 卡斯柯信号有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-114048842-A | Main shaft reliability prediction method of gradient descent optimization neural network | 沈阳航空航天大学 | 2022-02-15 | — | — | CN | claimed |
| CN-109746766-B | Method and system for determining temperature field of wear zone of rear cutter face of integral end mill | 哈尔滨理工大学 | 2022-01-25 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242504-A1 | DEUTERIUM-ENRICHED PIPERIDINONYL-OXOISOINDOLINYL ACETAMIDES AND METHODS OF TREATING MEDICAL DISORDERS USING SAME | EGLN3, HPGDS, EGLN2 | RAD51 429/4885RAD1 2212/4885BCL2A1 2442/4885 |
| US-20250320192-A1 | DEUTERIUM-ENRICHED PIPERIDINONYL-OXOISOINDOLINYL ACETAMIDES AND METHODS OF TREATING MEDICAL DISORDERS USING SAME | EGLN3, HPGDS, EGLN2 | RAD51 429/4885RAD1 2212/4885BCL2A1 2442/4885 |
| US-20250345443-A1 | PHARMACEUTICAL COMPOUND AND USE THEREOF | SLC10A1, FURIN, SELL | RAD51 4829/4885RAD1 4885/4885BCL2A1 4637/4885 |
| US-11535603-B1 | Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using same | EGLN3, HPGDS, EGLN2 | RAD51 429/4885RAD1 2212/4885BCL2A1 2442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.